The inhibition of CYBB in zebrafish embryos leads to lipid metabolism disorders and excessive activation of the TLR4/NF-κB pathway, triggering liver injury and immune-inflammatory responses (62). Here, CYBB is linked to Disorder of lipid metabolism.